Moderna MRNA 深 滬
等待開盤 02-04 09:30:00 美东时间
42.20
-0.350
-0.82%
華盛通- 最 高44.17
- 今 開42.65
- 成交量 936.82万股
- 最 低 41.28
- 昨 收 42.55
- 總市值 165.00亿
- 52周最高 55.20
- 市盈率 靜 --
- 換手率 2.40%
- 52周最低 22.28
- 委 比 85.35%
- 總股本 3.91亿
- 歷史最高 497.49
- 量 比 0.74
- 振 幅 6.79%
- 歷史最低 11.54
- 每 手 1
- 風險率 5.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Spotlight on Moderna: Analyzing the Surge in Options Activity
Whales with a lot of money to spend have taken a noticeably bullish stance on M...
02-03 01:00
Moderna Stock Slips As Ambitious Cancer Trials Drag On
Moderna ( ($MRNA) ) has fallen by -8.17%. Read on to learn why. Moderna shares ...
01-31 22:01
美股1月涨跌榜 | Q2业绩全面碾压预期！SanDisk月涨近143%“带飞”存储板块；Bloom Energy月涨74.2%
Q2业绩全面碾压预期！SanDisk涨近143%“带飞”存储板块，美光、西数涨超45%；电力公司Bloom Energy涨74.2%，SOFC为AI数据中心供电商业闭环彻底打通>>
01-31 10:30
Moderna announces departure of medical chief
Moderna (MRNA) announced on Friday that the company’s chief medical officer, Jacqueline Miller, will resign effective Mar. 2, a little over a year after taking over the role. The Cambridge, Massachuse...
01-31 01:13
Moderna CMO Jacqueline Miller to step down
Moderna CMO Jacqueline Miller to step down Jan 30 (Reuters) - Moderna's MRNA.O Chief Medical Officer Jacqueline Miller, who led the development of the company's mRNA-based COVID-19 vaccine Spikevax , will step down effective March 2, the vaccine maker said on Friday. Miller joined Moderna in 2020 as
01-30 22:01
Moderna Appoints David Berman as Chief Development Officer
Moderna Appoints David Berman as Chief Development Officer Moderna Inc. has appointed Dr. David Berman as Chief Development Officer, effective March 2, 2026. Dr. Jacqueline Miller will step down as Chief Medical Officer and will remain as a consultant to assist with the transition. Dr. Berman will j
01-30 20:30
BRIEF-Recordati Announces Collaboration With Moderna For Mrna-3927
BRIEF-Recordati Announces Collaboration With Moderna For Mrna-3927 Jan 29 (Reuters) - Moderna Inc MRNA.O : RECORDATI - ANNOUNCES COLLABORATION WITH MODERNA FOR MRNA-3927 RECORDATI - UNDER DEAL, TO PAY MODERNA $50 MILLION UPFRONT AND $110 MILLION IN MILESTONES RECORDATI: UNDER DEAL, MODERNA IS ALSO E
01-30 06:21
U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio
U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio Jan 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AGNC Investment, Brown & Brown and Korro Bio, on Thursday. HIGHLIGHTS * AGNC Investment Corp AGNC.O :
01-29 15:54
